Gelesis Holdings, Inc. (GLSHQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 21, 2025
Gelesis Holdings Market Cap
Gelesis Holdings has a market cap or net worth of $7.33 thousand as of May 9, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
7.33K
Enterprise Value
n/a
Revenue
12.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 24, 2020, Gelesis Holdings's market cap has decreased from 339.83M to 7.33K, a decrease of -100.00%. That is a compound annual growth rate of -90.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 7.33K | - |
| Dec 30, 2024 | 7.33K | -93.33% |
| Dec 29, 2023 | 110.00K | -99.48% |
| Dec 30, 2022 | 21.21M | -93.83% |
| Dec 31, 2021 | 343.62M | -1.87% |
| Dec 31, 2020 | 350.18M | 3.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.67B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 705.84M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 536.22M |
| CytoDyn | 510.97M |
| Elite Pharmaceuticals | 454.55M |
| Northwest Biotherapeutics | 417.15M |